Literature DB >> 27884348

Prognostic relevance of hematological profile before resection for colorectal liver metastases.

Ulf Kulik1, Harald Schrem2, Hueseyin Bektas3, Juergen Klempnauer3, Frank Lehner3.   

Abstract

BACKGROUND: Although alterations of hematological profile and especially elevated platelet counts were reported to influence survival in primary colorectal cancer, its prognostic relevance before the surgical treatment of colorectal liver metastases (CLM) is mainly unclear. Therefore, the aim of this study was to analyze the impact of these factors on overall survival following liver resection of CLM.
MATERIALS AND METHODS: The surgical treatment of primary CLM between 1994 and 2012 in 983 patients was retrospectively analyzed using univariable and multivariable Cox regression models.
RESULTS: In the multivariable analyses, a preoperative anemia was independently associated with inferior overall outcome (P = 0.005, hazard ratio: 1.355). However, with only 2.7% of all cases, an elevation of preoperative platelets was not a frequent finding and no independent impact on survival (P = 0.834). Furthermore, abnormal hemoglobin and platelet values had no impact on rate of surgical revisions due to bleeding complications (P = 0.962 and P = 0.671, respectively), but a potential interaction between abnormal hemoglobin and platelet values and the amount of transfused packed red blood cells (P = 0.004 and P < 0.001, respectively) was observed.
CONCLUSIONS: Preoperative anemia is statistically significantly associated with inferior overall survival following resection of CLM and might define a new prognostic marker. Preoperative elevated platelets were not a frequent finding and showed no influence on overall survival. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal liver metastases; Mortality; Multivariable regression; Risk factors for survival; Risk-adjusted analysis

Mesh:

Substances:

Year:  2016        PMID: 27884348     DOI: 10.1016/j.jss.2016.08.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Prognostic value of thrombocytosis in patients undergoing surgery for colorectal cancer with synchronous liver metastases.

Authors:  C Pedrazzani; G Turri; G Mantovani; C Conti; R Ziello; S Conci; T Campagnaro; A Ruzzenente; A Guglielmi
Journal:  Clin Transl Oncol       Date:  2019-04-02       Impact factor: 3.405

2.  Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.

Authors:  Tobias Getzin; Faikah Gueler; Björn Hartleben; Marcel Gutberlet; Anja Thorenz; Rongjun Chen; Martin Meier; Jan Hinrich Bräsen; Thorsten Derlin; Dagmar Hartung; Hannah A S Lang; Hermann Haller; Frank Wacker; Song Rong; Katja Hueper
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

Review 3.  Impact of perioperative blood transfusion on clinical outcomes in patients with colorectal liver metastasis after hepatectomy: a meta-analysis.

Authors:  Xinghua Lyu; Wenhui Qiao; Debang Li; Yufang Leng
Journal:  Oncotarget       Date:  2017-06-20

4.  Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases.

Authors:  Ulf Kulik; Mareike Plohmann-Meyer; Jill Gwiasda; Joline Kolb; Daniel Meyer; Alexander Kaltenborn; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  HPB Surg       Date:  2018-10-21

5.  Improving the treatment of pre-operative anemia in hepato-pancreato-biliary patients: a quality improvement initiative.

Authors:  Terry M Zwiep; Richard W D Gilbert; Husein Moloo; Donna Touchie; Guillaume Martel; Tom Wallace; Kimberly A Bertens
Journal:  Patient Saf Surg       Date:  2020-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.